Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | GBP 9 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.38% |
Inception/ Listing Date | 20 September 2022 |
Distribution policy | Distributing |
Distribution frequency | Annually |
Fund domicile | Ireland |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | HSBC Securities Services (Ireland) |
Investment Advisor | |
Custodian Bank | HSBC Bank plc |
Revision Company | - |
Fiscal Year End | 31 December |
Swiss representative | NO |
Swiss paying agent | NO |
Germany | 30% tax rebate |
Switzerland | No ESTV Reporting |
Austria | Non-Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
UnitedHealth Group | 8.90% |
Eli Lilly & Co | 8.67% |
Novo Nordisk | 6.41% |
AbbVie | 5.90% |
Merck & Co | 3.61% |
Novartis | 3.57% |
Abbott Laboratories | 3.49% |
AstraZeneca | 3.47% |
Thermo Fisher Scientific | 3.05% |
Roche Holding | 2.97% |
United States | 66.64% |
Switzerland | 7.92% |
United Kingdom | 5.29% |
Japan | 4.99% |
Other | 15.16% |
Health Care | 92.92% |
Consumer Discretionary | 0.46% |
Other | 6.62% |
YTD | +5.37% |
1 month | -1.56% |
3 months | +4.10% |
6 months | +7.86% |
1 year | +5.48% |
3 years | - |
5 years | - |
Since inception (MAX) | +9.35% |
2023 | -0.11% |
2022 | - |
2021 | - |
2020 | - |
Current dividend yield | 0.92% |
Dividends (last 12 months) | GBP 0.09 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.09 | 0.96% |
Volatility 1 year | 11.38% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.48 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -9.69% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -11.45% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WELG | - - | - - | - |
XETRA | USD | WELZ | WELZ GY IWELZ | WELGUSD.DE IWELZUSDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | EUR | WELG | WELG GY IWELG | WELG.DE IWELGEURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 983 | 0.40% p.a. | Accumulating | Sampling |
iShares Ageing Population UCITS ETF | 441 | 0.40% p.a. | Accumulating | Sampling |
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 138 | 0.35% p.a. | Accumulating | Full replication |
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 87 | 0.18% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0.35% p.a. | Accumulating | Full replication |